Clinical Trials and Research Projects  
Vet Clinical Trials

Vet Clinical Trials


Browse by category

Powered By VIN


Category: Dogs

Effects of Cyclosporine on Activated T-Cell Expression of IL-2 and IFN-gamma in Dogs (Study Closed)
May 16, 2016 (published)
Mark Rishniw

You do not have permission to view this document: [7342428]!

Study Start Date: 05/01/2016
Study End Date: 05/01/2017

Effects of Cyclosoprine on Activated T Cell Expression of IL-2 and IFN-gamma in Dogs

Dogs with anal furunculosis are often treated with the immunosuppressive drug cyclosporine. Our laboratory has developed an assay, "activated T- cell expression of IL-2 and IFN-gamma", to fine tune cyclosporine doses. Interpretation of the assay is optimized by knowing pre-treatment levels. Our laboratory has good pre-treatment assay data for most diseases, but lacks sufficient samples from dogs with anal furunculosis.

Study Design:
Case series for assay validation

Sample Size:
15 samples

Inclusion Criteria:

  • Canine anal furunculosis, diagnosed based on classic clinical appearance that has not yet been treated with cyclosporine.

Exclusion Criteria:

  • Anal furunculosis that has been treated with cyclosporine

A single blood sample from dogs in the early treatment phases of anal furunculosis, before they receive cyclosporine. A single 3 ml heparinized sample, collected and submitted in the first half of the week, will suffice.

Study Website:
Further sample submission details are on our web- site:

You do not have permission to view this document: [7342518]!

For the first 15 samples sent in for the anal furunculosis baseline project, we are offering the next post-cyclosporine T cell assay (whether on the anal furunculosis patient, or another patient) at no charge. Just remind us when you are submitting another clinical sample.

You do not have permission to view this document: [7342448]!

Full Disclosure information:
The study is funded by a grant from Mississippi State University.

The investigator does not have a conflict of interest.

Have questions or feedback?